According to a market report by Lucintel, the future of the global circulating tumor cell and cancer stem cell market looks promising with opportunities in the hospital, diagnostic laboratory, and research institute markets. The global circulating tumor cell and cancer stem cell market is expected to grow with a CAGR of 11.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of cancer cases, the rising demand for early cancer detection, and the growing focus on personalized cancer treatments.
A more than 150-page report to understand trends, opportunity and forecast in circulating tumor cell and cancer stem cell market to 2031 by cancer type (breast cancer, prostate cancer, colorectal cancer, lung cancer, and others), technology (CTC enrichment, CTC detection, CTC analysis, CSC identification, CSC isolation, and CSC characterization), application (clinical diagnostics, research & development, liquid biopsy, prognosis, therapy selection, and others), end use (hospitals, diagnostic laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the cancer type category, breast cancer is expected to witness the highest growth over the forecast period.
Within the end use category, hospital is expected to witness the highest growth.
Download sample by clicking on circulating tumor cell and cancer stem cell market
In terms of region, North America is expected to witness the highest growth over the forecast period.
ApoCell Inc., Biocept Inc., CellTraffix Inc., Clearbridge BioMedics Pte Ltd., Epic Sciences Inc., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc., IVDiagnostics Inc., Janssen Diagnostics LLC are the major suppliers in the circulating tumor cell and cancer stem cell market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Indium Gallium Arsenide Sensor Market
Industrial Microfocus X-ray Tube Market
Industrial Thermal Processing Equipment Market
Liquid Food Storage Tank Market
Liquid Molding Compound Market